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ABSTRACT 
Objective: A systematic review to evaluate the various genotyping tools and study 
strategies employed to define genetic susceptibility to periodontitis. 
Methods: The review was performed in accordance with Preferred Reporting Items for 
Systematic Review and Meta-Analysis guidelines. The search for publications referring to 
the genetic bases of periodontal disease was performed on the MEDLINE-PubMed and 
Cochrane Library databases, on trials registers, and on the web pages of regulatory 
agencies. 
Results: We found 2439 potentially eligible articles, of which only 25 satisfied the 
established inclusion criteria and were processed for data extraction. The review revealed 
marked heterogeneity between studies, caused in part by the lack of a universally 
accepted definition for periodontitis phenotypes and by the variety of genotyping tools 
available. The most commonly used technique was genotyping candidate genes. 
Conclusion: The few rigorous studies that have been published on genetic susceptibility 
to periodontitis are subject to severe methodological bias due to their design and the 
genotyping tools employed. Despite their limitations, candidate gene studies continue to 
be the predominant methodological approach, rather than genome-wide association 
studies. Further studies must be designed using a universally accepted, validated 
diagnostic criterion for periodontitis, analysing multiple genes and polymorphisms in 
combination with rare variants. 
 
 










The existence of a genetic component to periodontal disease (PD) has been confirmed in 
twin studies, which estimate that 38% to 82% of populational variability in the clinical 
parameters of periodontal disease is attributable to genetic factors (Michalowicz et al., 
1991a, 19991b, 2000). It has been suggested that the genetic component of chronic 
periodontitis (CP) might have been overestimated (Torres de Heens, Loos, & van der 
Velden, 2010), but that it is more relevant in aggressive periodontitis (AgP), as has been 
demonstrated in familial aggregation studies (Benjamin & Baer, 1967; Marazita et al., 
1994; Saxén & Nevanlinna, 1984). 
As with diabetes, certain types of cancer, Alzheimer's disease, Crohn's disease, and 
schizophrenia, PD is considered to be genetically complex, resulting from the interaction 
of genes with the environment (Laine, Crielaard, & Loos, 2012; Stabholz, Soskolne, & 
Shapira, 2010). Two main hypotheses have been proposed regarding the genetic basis of 
complex diseases. The first is the common disease/common variant (CD/CV) hypothesis 
(Reich & Lander, 2001), in which it is assumed that genetic variants common in the 
general population but which individually have a weak effect are those that have the 
greatest influence on genetic susceptibility to complex disorders. These genetic variants 
are called polymorphisms  when they are present with a frequency of at least 1% in the 
population (Hart, Marazita, & Wright, 2000). They include single nucleotide 
polymorphisms (SNPs), which are very common in the genome and consist of a change of 
one nucleotide base for another. The second hypothesis is the common disease/rare 
variant (CD/RV) hypothesis, in which the main contributors to susceptibility to complex 
diseases are rare variants (minor allele frequency <1%) present in the genome (Pritchard, 
2001). The hypothesis that is deemed valid will thus determine the strategy applied to 
detect variants that favour disease. Most PD studies assume the CD/CV hypothesis; thus, 
the most common strategy consists of the search for polymorphisms that could affect the 
periodontal disease phenotype. 
One of the first studies to identify genetic markers for PD was published in 1997 by 
Kornman et al (Kornman et al., 1997). Those authors analysed several polymorphisms of 
the interleukin-1 (IL-1) family (polymorphisms of IL-1A at position-889, of IL-1B at 
position -511 and +3953, and of IL-1RN intron 2) and found evidence of an association 
between IL-1 and the severity of PD in nonsmokers, differentiating between individuals 
with mild and severe PD. 
These encouraging results led to further genetic studies on PD that applied distinct 
methodological designs. One of those was the genome-wide linkage analysis, which has 
been widely used to study complex diseases such as schizophrenia (Stefansson et al., 
2002) and type 2 diabetes (Nisticò et al., 1996); however, in contrast to its notable efficacy 
in the genetic mapping of Mendelian diseases, the technique has limited usefulness in the 
detection of alleles with a weak effect, which are common in complex diseases (Plomin, 
Haworth, & Davis, 2010). 
Another design is the association study, which enables relationships to be established 
between a specific polymorphism and a disease or phenotypic trait. This approach 
determines differences in the frequency of a genetic marker in cases and controls to 
indicate a relationship between that marker and the disorder under investigation. The two 
principal methods in this context are the candidate gene association study (CGAS) and 
the genome-wide association study (GWAS). The CGAS is based on an analysis of genes 
that are linked to a certain disease through their function or their position in the genome. It 
is therefore essential for investigators to understand the pathophysiology of a disorder 
before performing this type of study. Based on the promising results from what was 
considered the first CGAS (Kornman et al., 1997), this type of design became the most 
widely used to analyse the genetics of PD. However, the very rapid development of 
genotyping technologies in recent years has led to substitution of CGASs with GWASs, 
because these latter studies theoretically enable us to identify new genetic markers. The 
first GWAS to study periodontitis was published in 2010 and established an association 
between SNP rs1537415, present in gene GLT6D1 (glycosyltransferase), and AgP 
(Schaefer et al., 2010a). 
Given the complexity of PD, the role of genetics is significant in its onset, progression, and 
severity (Albandar & Tinoco, 2002). The identification of genetic risk factors associated 
with PD is therefore essential to improving prevention and treatment strategies for this 
disease (Song, Yao, He, & Xu, 2015). 
The objective of this systematic review was to evaluate the genotyping tools and study 
strategies used in the literature to establish the genetic bases of PD and to determine their 
main limitations. 
 
MATERIALS AND METHODS  
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
review process was used to perform the present systematic review (Moher, Liberati, 
Tetzlaff, Altman, & PRISMA Group, 2009).The PRISMA checklist was followed in both the 
planning and the reporting of the review. 
Focused Question 
The research question formulated was based on PECO framework: If in the studies 
performed on patients with periodontitis reported in the literature (Population) in which the 
genetic basis of susceptibility to periodontal disease was determined (Exposition), we then 
analyse the limitations and potential biases of the genotyping tools used (Control), are the 
validity and reliability of the results confirmed (Outcome)? 
 
Eligibility criteria 
The following inclusion criteria were applied: studies published in English; case-control 
design; specification of the PD phenotype; a sample size equal to or greater than 100 
individuals in either the case or control group, or in both groups. No limitations were 
placed on the year of publication or the age, population group, or country of origin of the 
participants. Publications with any of the following potential biases were excluded: a study 
group that included individuals with systemic diseases that could favour the onset or 
augment the severity of PD; patients treated with drugs that provoke gingival hyperplasia; 
and pregnant women (pregnancy gingivitis). Reviews and meta-analyses were also 
excluded, even if they referred to genetic susceptibility to PD. We used the number of 
SNPs  analysed as inclusion criteria for candidate gene studies. There have been many 
studies of this type that have analysed a reduced number of SNPs; they are generally 
lacking in quality control and have a lack of appropriate statistical corrections, Hardy-
Weinberg equilibrium analysis or correspondence of cases and controls with a population 
background. Thus, due to the criteria that define the copy number variations (CNVs) (Lin, 
Naj, & Wang, 2013; Merikangas, Corvin, & Gallagher, 2009) and the limitations observed 




The search for articles was performed using the electronic databases of the National 
Library of Medicine, Washington DC, USA (MEDLINE, PubMed), and of the Cochrane 
Library, in addition to trial registers and the web pages of regulatory agencies. A manual 
search was performed of the most relevant journals in the field of periodontics of the last 
10 years. In addition, "snowball" methods were also applied such as pursuing references 
of references from all selected full-text papers. The search was performed up to Jan 2018. 
Study selection was performed in accordance with the most recent recommendations of 
the Centre for Reviews and Dissemination of the University of York (Centre for Reviews 
and Dissemination, University of York, 2008).The following keywords were used: 
“periodontitis” and “periodontal disease”, in combination with “genetic polymorphism”, 
“single nucleotide polymorphism”, “mutation”, “genes”, “new genome sequencing”, “exome 
sequencing”, “whole genome sequencing”, “CNV”, and “genome wide association”. The 
“humans” filter was selected for all searches. 
Search strategy 
The search strategy used a combination of Medical Subject Headings terms and 
keywords for MEDLINE and Cochrane Library. The search strategy used is described in 
the supporting information (appendix S2). 
Study selection 
Study selection was performed using a two-stage screening process performed by two 
independent reviewers (P. D. and A. de C.). Disagreement on the inclusion or exclusion of 
a specific article was resolved by consensus. In the first phase, studies that did not satisfy 
the inclusion criteria were eliminated, as were those considered irrelevant based on their 
title or the content of the abstract. A full-text review of the remaining articles was then 
performed to confirm the inclusion criteria and to check quality. The most relevant data 
were then extracted. Concordance between the two reviewers was calculated using the 
Kappa coefficient for the first and second screenings. 
Data collection process/data items 
The eligibility criteria were applied after agreement had been achieved between the two 
reviewers for the studies to be included in the review. Data were gathered on the general 
characteristics of the study (year of publication, clinical parameters recorded, number of 
SNPs studied, genotyping method) and on their populational characteristics (population, 
age, number of participants, smoking, diabetes). The extracted data were presented in the 
same form in which they were described in the original studies, except for those studies 
with the same design but different forms of presentation of the results, in which case the 
results were processed to facilitate extraction of the data of interest.  
Risk of bias in individual studies 
We aimed to assess the risk of bias of the included studies through sensitivity analysis. 
The risk of bias/quality assessment for the individual studies was assessed according to 
the suggested scale (score of 0 to 20) adapted to genetic analysis of periodontal genetic 
association studies (Nibali, 2013). 
Summary measures/synthesis of results 
No meta-analysis was attempted for this systematic review; thus, no formal statistical 




The search provided a total of 2439 potentially selectable articles (MEDLINE PubMed, 
n=2392; Cochrane, n=47; other sources, n=0) (Figure 1). Duplicate articles were 
eliminated by comparing the results obtained with each database, leaving 2412 articles 
potentially useful for the review. The titles and abstracts of these studies were then 
examined, and 87 articles were selected for full-text review; of these, 62 were excluded 
because they did not satisfy the inclusion criteria. This left a final count of only 25 studies 
for analysis in this review. The Kappa value for inter-reviewer concordance was 0.95 for 
the first screening (by title and abstract) and 0.89 for the second screening (full-text 
review). 
We detected several publications in which samples derived from the same study group 
were analysed. In 2010, Chai et al. analysed samples gathered between May 2005 and 
August 2007 from a primary care clinic in the Prince Philip Dental Hospital of the Faculty 
of Dentistry of the University of Hong Kong; they analysed the SNPs present in C5 (Chai, 
Song, Zee, & Leung, 2010a) and FCGR (Chai, Song, Zee, & Leung, 2010b). In 2010, 
Schaefer et al. conducted the first GWAS to study periodontitis (Schaefer et al., 2010a). 
They analysed the German population with AgP and replicated the association in a panel 
of Dutch patients with AgP. Subsequently, these cohorts were examined in a large 
candidate-gene association study by Schaefer et al. in 2014 and 2015 (Schaefer et al., 
2014; Schaefer et al., 2015). Also in 2010, Schaefer et al. analysed 12 SNPs in the gene 
DEFB1 in individuals from Germany and the Netherlands with CP and AgP (Schaefer et 
al., 2010), and in 2011 performed an analysis of 51 SNPs in genes CDKN2A and 
CDKN2B for individuals with AgP and of 37 SNPs in the same genes but in individuals 
with CP (Schaefer et al., 2011). Also in 2011, Scapoli et al. studied 14 candidate genes, 
including some belonging to the IL-1 cluster that had already been studied a year earlier in 
the same population sample (with the exception of 25 new participants from the University 
of Turin) (Scapoli et al., 2010, 2011) and with the same results. In 2014, de Jong et al. (de 
Jong et al., 2014) analysed cases and controls described and studied previously by 
Schaefer et al. in 2010 (Schaefer et al., 2010a). The difference between the two studies 
was that de Jong et al. only investigated SNPs in genes SLC23A1 and SLC23A2 instead 
of the whole genome, as the earlier study had done. One year later, in 2015, Schaefer et 
al. (Schaefer et al., 2015), investigating the genetic risk factors shared between coronary 
artery disease and periodontitis, analysed the same German/Austrian, Dutch, and Turkish 
cohorts as Schaefer et al. in 2010 and 2013 (Schaefer et al., 2010a, 2013). In addition, 
patients from the Netherlands and from Turkey were studied at a whole genome level by 
Munz et al. in 2017 (Munz et al. 2017). Finally, Offenbacher et al. (Offenbacher et al., 
2016) and Munz et al. (Munz et al., 2017) analysed the same German population whose 
cases were previously described by Schaefer 2015 and whose controls were recruited 
from the Competence Network FOCUS (Food Chain Plus) (Müller et al., 2015), the 
Dortmunder Gesundheits studie (Berger, 2012), and the Heinz Nixdorf Recall Studies 1-3 
(Schmermund et al., 2002). 
Study characteristics 
The principal characteristics of the 25 studies selected for this review are summarised in 
Table 1 and in the following sections: Diagnosis of periodontal disease, Demographics, 
Quality assessment, Clinical parameters, Study methodology, Genotyping method, and 
Genetic results. 
Diagnosis of periodontal disease 
Most of the studies (20 of 25) were published in 2010 or later; nevertheless, the diagnostic 
criteria for the PD phenotype in ten of these studies were those proposed by Armitage in 
1999 (Armitage, 1999), and another three used other sources from that same year 
(Flemmig, 1999; Lang et al., 1999). In the remaining 12 studies, the diagnostic criteria 
used to determine the phenotype were not specified, although the values of the clinical 
parameters used to select the participants were given.  
Demographics 
The population samples in nine articles included German individuals and in six included 
Dutch individuals. The populations in the remaining studies were from Japan (4), China 
(4), Italy (3), Brazil (2), United States (2), England (1), Macedonia (1), and Turkey (1). The 
sample size of the studies reviewed varied between 208 (Schaefer, 2010b) and 8295 
participants (Munz et al., 2017) (Table 1). The mean age — obtained by weighting the 
means across studies — of the individuals with AgP was 37 years and of those with CP 
was 50 years. Data on the participants' smoking habits were only recorded in 17 of the 25 
studies included in the review (Chai et al, 2010a, Chai et al, 2010b; de Jong et al., 2014; 
Feng et al., 2014; Fiebig et al., 2008; Kobayashi et al., 2009a, 2009b; Munz et al., 2017; 
Offenbacher et al., 2016; Schaefer et al., 2010a, 2010b, 2011, 2013, 2014, 2015; Shang 
et al., 2016; Zupin et al., 2017). In one study, smoking was considered an exclusion 
criterion (Zhang et al., 2014), and seven provided no specific data on smoking (Table 1). 
The number of individuals with diabetes was only reported in seven studies (de Jong et 
al., 2014; Feng et al., 2014; Offenbacher et al., 2016; Schaefer et al., 2010a, 2010b, 2011; 
Zhang et al., 2014), and a history of diabetes was considered an exclusion criterion in six 
studies (Chai et al., 2010a, 2010b; Fiebig et al., 2008; Kobayashi et al., 2009b; Schaefer 
et al., 2015; Shang et al., 2016).The remaining 12 articles made no reference to diabetes 
(Table 1). 
Quality assessment 
Random sample selection from the general population was performed in eight studies (de 
Jong et al., 2014; Schaefer et al., 2010a, 2010b, 2011, 2013, 2014; Zhang et al., 2014; 
Zupin et al., 2017), whereas in 16 studies the participants were recruited from hospitals, 
dental clinics, research centres, and universities. Randomisation of participant selection 
was not specified in one study, though the origin of the controls was a blood transfusion 
centre _considered as the general population_ and the possibility that individuals with 
periodontitis had been included was noted (Brett et al., 2005). 
Twenty of the publications examined did not confirm the presence of at least one 
examiner or specify his or her level of training (Atanasovska-Stojanovska, Popovska, 
Trajkov, & Spiroski, 2013; Brett et al., 2005; Chai et al., 2010a, 2010b; de Jong et al., 
2014; Feng et al., 2014; Gunji et al., 2007; Kobayashi et al., 2009a, 2009b; Munz et al., 
2017; Offenbacher et al., 2016; Scapoli et al., 2010, 2011; Schaefer et al., 2010a, 2013, 
2014, 2015; Suzuki et al., 2004; Zhang et al., 2014; Zupin et al., 2017). In two studies, the 
clinical parameters were gathered by a single examiner with experience (Schaefer et al., 
2010b, 2011), and in two (Letra et al., 2012; Shang et al., 2016) of the remaining three 
studies, the degree of concordance between the examiners was defined using Cohen's 
kappa coefficient (Garlet et al., 2012). 
Clinical parameters 
The oral health status variables recorded in the studies and included in the review are 
summarised in Table 3. The following parameters were evaluated most frequently: 
probing pocket depth, also defined as probing depth (14 studies) (Atanasovska-
Stojanovska et al., 2013; Chai et al., 2010a, 2010b; Gunji et al., 2007; Kobayashi et al., 
2009a, 2009b; Letra et al., 2012; Offenbacher et al., 2016; Schaefer et al., 2010b, 2011; 
Shang et al., 2016; Suzuki et al., 2004; Zhang et al., 2014; Zupin et al., 2017); clinical 
attachment loss, also defined as clinical attachment level or probing attachment level (13 
studies) (Atanasovska-Stojanovska et al., 2013; Chai et al., 2010a, 2010b; Feng et al., 
2014; Kobayashi et al., 2009a, 2009b; Letra et al., 2012; Offenbacher et al., 2016; 
Schaefer et al., 2010b, 2011; Shang et al., 2016; Zhang et al., 2014; Zupin et al., 2017); 
bleeding on probing (11 studies) (Atanasovska-Stojanovska et al., 2013; Chai et al., 
2010a, 2010b; Kobayashi et al., 2009a, 2009b; Offenbacher et al., 2016;Schaefer et al., 
2010b, 2011; Suzuki et al., 2004; Zhang et al., 2014; Zupin et al., 2017); and alveolar 
bone loss (12 studies) (Chai et al., 2010a; de Jong et al., 2014; Fiebig et al., 2008; 
Kobayashi et al., 2009b; Schaefer et al., 2010a, 2010b, 2011, 2013,2014 2015; Suzuki et 
al., 2004; Zhang et al., 2014). Some of the selected studies also reported other variables, 
including the number of natural teeth (eight studies) (Chai et al., 2010b; Fiebig et al., 
2008; Gunji et al., 2007; Kobayashi et al., 2009b; Schaefer et al., 2010b, 2011, 2014; 
Zupin et al., 2017); variables related to the accumulation of bacterial plaque (four studies) 
(Kobayashi et al., 2009a, 2009b; Offenbacher et al., 2016; Zupin et al., 2017); furcation 
exposure (3 studies) (Schaefer et al., 2010b, 2011, 2014); tooth mobility (two studies) 
(Suzuki et al., 2004; Zhang et al., 2014); loss of interproximal insertion (two studies) 
(Scapoli et al., 2010, 2011); the gingival index (two studies) (Atanasovska-Stojanovska et 
al., 2013; Offenbacher et al., 2016); and degree of gingival recession (two studies) (Zhang 
et al., 2014; Zupin et al., 2017). 
Study methodology 
Twenty-one (84%) of the 25 selected publications used the CGAS design (Atanasovska-
Stojanovska et al., 2013; Brett et al., 2005; Chai et al., 2010a, 2010b; de Jong et al., 2014; 
Fiebig et al., 2008; Gunji et al., 2007; Kobayashi et al., 2009a, 2009b; Letra et al., 2012; 
Scapoli et al., 2010, 2011; Schaefer et al., 2010b, 2011, 2013, 2014, 2015; Shang et al., 
2016; Suzuki et al., 2004; Zhang et al., 2014; Zupin et al., 2017). Five of those studies 
analysed a single candidate gene: formyl peptide receptor 1 (FPR-1), β-defensin 1 
(DEFB1), complement component 5 (C5), Fc γ receptor (FCGR), and interleukin-8 (IL-8) 
(Chai et al., 2010a, 2010b; Gunji et al., 2007; Schaefer et al., 2010b; Zhang et al., 2014). 
Of the 13 articles that used GWAS methodology, nine were excluded from the review 
because they did not satisfy the selection criteria (Divaris et al., 2012, 2013; Freitag-Wolf 
et al., 2014; Hong, Shin, Ahn, Lee, & Kim, 2015; Rhodin et al., 2014; Sanders et al., 2017; 
Shaffer et al., 2014; Shimizu et al., 2015; Teumer et al., 2013) (Table 2); only four studies 
were included (16% of the total of articles included in the review) (Feng et al., 2014; Munz 
et al., 2017; Offenbacher et al., 2016; Schaefer et al., 2010a). Only the data related to the 
analysis of the independent German sample of the series by Offenbacher et al. 
(Offenbacher et al., 2016) were included in the review. The data corresponding to the 
GWAS initially performed were not examined because the controls of the studied cohort 
included patients with periodontitis. 
Genotyping method  
In seven of the selected studies, the genotyping of cases and of controls was performed 
using TaqMan probes (Fiebig et al., 2008; Kobayashi et al., 2009b; Letra et al., 2012; 
Munz et al., 2017; Schaefer et al., 2010b, 2011; Suzuki et al., 2004). The Sequenom 
platform was used in seven of the review articles (Chai et al., 2010a, 2010b; Munz et al., 
2017; Scapoli et al., 2010, 2011; Shang et al., 2016; Zhang et al., 2014) and the Illumina 
platform in another seven publications (Munz et al., 2017; Offenbacher et al., 2016; 
Schaefer et al., 2013, 2014, 2015; Zhang et al., 2014; Zupin et al., 2017). Polymerase 
chain reaction (PCR) was used as the genotyping method in two studies (Brett et al., 
2005; Scapoli et al., 2011), and a variant of PCR in a further two (Atanasovska-
Stojanovska et al., 2013; Gunji et al., 2007) (restriction fragment length polymorphism 
[RFLP]PCR and single specific primer [SSP]PCR, respectively). The following genotyping 
platforms were employed in the remaining articles: Affymetrix (de Jong et al., 2014; 
Schaefer et al., 2010a, 2015), nano-Invader DNA chip system (Kobayashi et al., 2009a, 
2009b), and SNPlex (Schaefer et al., 2010b, 2011) (Table 4). 
Appendix S3 reports the genotyping technology used in the various studies in relation to 
the level of evidence of association between genes and PD. The greatest level of 
evidence in the present review (moderate) was achieved by the SLC23A1 and 
SLC23A2genes. De Jong et al. found a significant association between these genes and 
AgP in whites (de Jong et al., 2014). Cases and controls were genotyped using the 
Affymetrix Human Mapping 500K Array set. 
Genetic results 
In 21 articles, an association was established between some of the SNPs analysed and 
the presence of CP, AgP, or PD in general (Table 4). In the four remaining studies, no 
association of any type was found between the polymorphisms studied and PD (Fiebig et 
al., 2008; Kobayashi et al., 2009a; Offenbacher et al., 2016; Scapoli et al., 2010). In the 
present systematic review, a significant association between the presence of PD and a 
total of 54 SNPs was found. Of the 54 SNPs, 29 were associated with AgP, 21 with CP, 
two with both PD phenotypes, and two with PD in general. 
The most common associations in the studies reviewed were between the interleukin-6 
gene (IL6) and CP and AgP (Brett et al., 2005; Scapoli et al., 2011), between the vitamin 
D receptor gene (VDR) and CP (Brett et al., 2005; Kobayashi et al., 2009b), and between 
the interleukin-1B gene (IL1B) and AgP and CP (Atanasovska-Stojanovska et al., 2013; 
Brett et al., 2005) (Table 4). However, the level of evidence of these associations was 
very weak (appendix S3). Another gene related to IL6, the interleukin-6 signal transducer 
(IL6ST), was found to be associated with AgP in the study conducted by Suzuki et al. 
(Suzuki et al., 2004); the odds ratios (ORs) for the SNPs present in these genes 
associated with PD were between 2.1 and 3.6. 
An OR>4 for four of the SNPs was significantly associated with PD. The polymorphisms 
were present in the genes PTGDS (OR,5.1), KRT23 (OR,6.3), EGF (OR,4.8), and C5 
(OR,6.1) (Chai et al., 2010a; Suzuki et al., 2004). 
Moderate evidence of an association was detected for only two genes, SLC23A1 and 
SLC23A2 (de Jong et al., 2014). In different studies and ethnic populations, several genes 
showed a weaker evidence association level with periodontal disease (appendix S3). 
 
 
Publication bias analysis 
Appendix S3 reports the results of the risk of bias analysis of individual studies included in 
the present review. The quality evaluation scale of the periodontal genetic association 
studies proposed by Nibali (Nibali, 2013) was used for the quality evaluation. CGAS and 
GWAS study quality scores ranged from a total of nine to a total of 14 (out of a maximum 
total of 20). In addition to the suggested scoring system, a threshold was used to 
determinate the “sturdiness” of the included publications, defining as “robust GWAS” the 
genome-wide association study with independent replication and a quality score >10 and 
as “robust CGAS” the candidate gene association study including at least 1000 
participants and with a quality score >10 (Nibali, Di Iorio, Tu, & Vieira, 2017). 
 
DISCUSSION 
This is the first systematic review, to our knowledge, to assess genotyping tools 
applied in genetic susceptibility studies on periodontal disease. The study of genetic 
associations with periodontitis can be carried out through various approaches, such as 
linkage analysis, family studies and association studies. However, due to its advantages 
the last approach is more widely used today. There are two major types of association 
studies: candidate gene and genome wide association studies. In the association studies 
carried out to date, the genotyping tools used to study the genetic basis of periodontal 
disease are diverse. TaqMan, Sequenom and Illumina are among the most commonly 
used genotyping platforms in the studies included in this review. The various approaches 
and tools used present certain limitations, which can lead to weak studies and erroneous 
associations. 
The present study is not exempt from several methodological limitations that should be 
considered when extrapolating our results. The influence of participant selection criteria 
on the results of studies on genetic susceptibility to PD remains unknown. The most 
controversial include variability in the definition and phenotype of PD and in the clinical 
parameters evaluated (American Academy of Periodontology Task Force Report on the 
Update to the 1999 Classification of Periodontal Diseases and Conditions, 2015; 
Armitage, 1999; Leroy, Eaton, & Savage, 2010; Tonetti, Claffey, & European Workshop in 
Periodontology group C, 2005) and in the inclusion of individuals with risk factors for PD, 
such as smoking (Kinane & Chestnutt, 2000) or diabetes (Salvi, Carollo-Bittel, & Lang, 
2008). The limitation of the literature search to English-language publications can also 
introduce a potential bias in the selection of articles (Moher, Pham, Lawson, & Klassen, 
2003; Pham, Klassen, Lawson, & Moher, 2005). We included only case-control studies 
with at least 100 participants because publications with small study cohorts (<100 
individuals) greatly contribute to the risk of false-positive or false-negative results 
(Burgner, Jamieson, & Blackwell, 2006; Newton-Cheh & Hirschhorn, 2005). Common or 
rare Copy Number Variations (CNVs) have been associated with genetic susceptibility for 
many diseases (Merikangas et al., 2009), and as such remain one of many viable 
categories of genomic variation to be explored for possible genetic contributions to 
disease (Lin et al., 2013). Threshold parameters for calling a CNV recommend analysing 
CNVs spanning at least 10 SNPs (Lin et al., 2013). However, the exclusion of articles with 
fewer than 10 SNPs could also constitute a methodological limitation of the present study. 
The predominant methodological design in the research evaluated was the candidate 
gene approach. In these association studies, a hypothesis is established a priori not only 
on the effect of certain genes on the risk of developing the disease but also on the 
presence of functional variants of these genes (Wilkening, Chen, Bermejo, & Canzian, 
2009). The genes targeted in this analysis were selected based on a previous 
understanding of the mechanisms involved in the molecular biology of the disease. This 
study design thus presents limitations, given that there could be genes that have an 
influence on the development of the disease but whose function or involvement in key 
pathways of the disease process remain undefined. The number of variants analysed in 
studies that use this design is therefore limited.  
GWASs also have a series of limitations. As occurs with other diseases, some of the 
genes associated with PD do not express a known biological function that could explain 
this association. In GWASs, it is essential to guarantee the power of the study, because 
the analysis of thousands of SNPs in a small sample will lead to a high risk of finding false 
associations, mainly because of random fluctuations in allele frequency between cases 
and controls (Schaefer, Jepsen, & Loos, 2011). In addition, GWASs need to be automated 
procedures for determining genotypes, because the assigned genotypes are not manually 
curated; thus, erroneous genotypes could go unnoticed thus introducing false positive 
associations. 
To date, 13 studies using GWAS methodology have been published in the databases 
selected, although only four satisfied the inclusion criteria for the present review (Schaefer 
et al., 2010a; Feng et al., 2014; Munz et al., 2017; Offenbacher et al., 2016). The first 
GWAS was performed by Schaefer et al. in 2010 (Schaefer et al., 2010a). Those authors 
analysed the genomes of 283 white individuals of German nationality with AgP and found 
a strong association between polymorphism rs1537415, located in gene GLT6D1, and 
AgP; this association was confirmed on repeating the study in a group of Dutch patients. 
Four years later, Feng et al. (Feng et al., 2014) used the GWAS technique to study the 
DNA of a group of 866 individuals from the dental register of the University of Pittsburgh. 
They analysed more than 500,000 SNPs and compared the 20 most relevant SNPs with a 
bank of samples from Brazilian patients, confirming that locus 16q22.3 contributed to the 
onset of CP. The authors of the two most recent GWASs agree in stating potential biases, 
such as the origin of the participant population, but they draw attention to the importance 
of GWAS in the design of future studies on the genetic bases of PD using multiple 
candidate genes. In 2016, Offenbacher et al. (Offenbacher et al., 2016) examined the 
association of more than 2.1 million markers with CP in a larger Dental Atherosclerosis 
Risk in Communities cohort (n=4766 Northern European). BEGAIN and UBE3D showed 
associations with severe CP and with moderate CP, respectively. These data were not 
included in the review because the control group was formed of individuals with mild 
periodontitis. They also analysed an independent German sample including 717 AgP 
cases, but no association was found (Offenbacher et al., 2016). The data corresponding 
to this cohort was included in the present review. One year later, Munz et al. conducted a 
GWAS using German and Dutch AgP samples (896 cases and 7104 controls), validated 
the association in a German CP sample (993 cases and 1416 controls), and replicated the 
positive findings in a Turkish AgP sample (223 cases and 564 controls). They found an 
association of SIGLEC5 and DEFA1A3 with periodontitis at a genome-wide level in the 
pooled samples (Munz et al., 2017). 
Of the four articles that used GWAS methodology and were included in the review, two 
were considered robust GWASs (Munz et al., 2017; Schaefer et al., 2010a), but the 
association of genes found with the PD was considered weak, because the results were 
not replicated in an independent GWAS or in a robust CGAS. Furthermore, association 
studies performed at a genome-wide level do not tag rare variants (Cirulli & Goldstein, 
2010). As stated in the CD/RV hypothesis, rare variants can contribute substantially to the 
risk of developing a disease such as PD. Rare variants have modest-to-small effect sizes 
on phenotypic variation; thus, their analysis has the potential to reveal novel variants 
implicated in complex diseases (Auer & Lettre, 2015). GWASs performed to date in PD 
have been based on the CD/CV hypothesis and have not taken rare variants into account 
in the design of the arrays, due to their high cost. The rapid improvement in the 
technology for measuring genomic variation has allowed the appearance of DNA 
sequencing-based approaches, such as next generation sequencing (NGS) and custom 
arrays. These tools help ascribe the contribution of rare variants to complex traits and 
diseases, thus eliminating this recognised limitation of GWASs (Cirulli & Goldstein, 2010). 
The studies included in the present review show considerable heterogeneity with regard to 
the genotyping techniques employed, reflecting ever-advancing technological 
developments. Chronologically, PCR was the first genotyping method to be described and 
was followed by variants of the same process (PCR-SSP and PCR-RFLP). PCR-SSP 
uses specific probes to amplify the DNA. Two PCRs are necessary to type a single SNP 
using this method, one with the specific primer and another with the common primer; 
additionally, this PCR variant requires a larger amount of DNA than other methods (Bugert 
et al., 2003). PCR-RFLP is based on the selective amplification of certain restriction 
fragments of a DNA sample, which gives robust and unequivocal results as long as a 
suitable endonuclease is used. The problem with this technique is the need for post-PCR 
DNA processing, which increases the risk of contamination (Dorak, 2006). Other studies 
have used the TaqMan genotyping system (Applied Biosystems, Foster City, CA, USA). 
This technology consists of a fluorophore covalently bonded to the 5´ terminus of a probe, 
which enables genotyping of the samples to be performed. By using allele-specific probes 
in the PCR, the amplification and detection steps are combined so that, in contrast to 
other methods, no additional post-PCR processing is required. The estimated error rate 
with this technique is less than 1 in every 2000 genotyping assays (Ranade et al., 2001). 
When the aim is to analyse a larger number of SNPs, these basic methods are costly and 
time-consuming if used alone, making them uneconomical in studies demanding a high 
yield. A system used for massive SNP analysis is SNPlex (Tobler et al., 2005), a method 
based on capillary electrophoresis. This method is a good alternative to previous 
genotyping methods because it only requires a small amount of DNA and uses easily 
accessible electrophoresis instruments (Tobler et al., 2005). Another genotyping tool is 
the novel nano-Invader DNA chip system. This approach is a miniaturised genotyping 
technique, in which the maximum sample volume is of 45 nanolitres. The sample is 
deposited on a polycarbonate slide with a capacity to perform 5040 tests per chip; in 
contrast to the other genotyping tools, this system does not require the PCR purification 
and hybridisation steps. PCR amplification and other time-intensive processing phases 
that require special apparatus to hold the amplified products are tedious but necessary 
when employing other methods of DNA typing, such as Sequenom (Sequenom, San 
Diego, CA, USA), Affymetrix (Affymetrix, High Wycombe, UK) and Illumina (Illumina, San 
Diego, CA, USA). Sequenom's MassARRAY technology incorporates a genotyping 
method based on the mass of the nucleotide added to the end of the primer. The mass is 
measured in a mass spectrometer using the MALDI-TOF technique (Jurinke, van den 
Boom, Cantor, & Köster, 2002). Given that this technique is based on an intrinsic property 
of the molecules  — their absolute mass (Brookes, 1999)— it avoids the introduction of 
modifications at a molecular level, such as the fluorescent marking characteristic of other 
methods (Meyer & Ueland, 2011). Sequenom's MassARRAY has certain drawbacks; it 
involves an initial purification stage that makes automation difficult and requires elaborate 
equipment, increasing its cost (Dorak, 2006). The Affymetrix technology employs probes 
synthesised directly on a quartz wafer. Two types of array were described in the selected 
publications: the Affymetrix Human Mapping 500K array set (including 500,000 SNPs) 
(Affymetrix & Inc, 2006) and the Affymetrix Genome-Wide Human SNP array 5.0 
(including 500,568 SNPs) (Affymetrix, 2007). In addition, Affymetrix makes it possible to 
perform a genome-wide analysis in a single experiment (Kennedy et al., 2003; Thermo 
Fisher Scientific Inc., 2017). The Illumina Human OmniBeadChip, Illumina Human 610-
Quav1_B BeadChip, and Illumina Inmunochip arrays are based on the Illumina Bead 
Array technology, which uses a fibreoptic or silica substrate onto which small silica beads 
(3 microns) are applied (Shen et al., 2005). Each bead is covered by hundreds of 
thousands of copies of a specific oligonucleotide, so that the fragments of DNA analysed 
will bind to the oligonucleotides if they possess the complementary region (Illumina, 
2015). The Illumina Immunochip, the most recent of the three arrays, is a custom-made 
Illumina Infinium genotyping array that includes 196,524 SNPs, designed to perform deep 
replication and fine mapping of established GWAS loci from major inflammatory and 
autoimmune diseases (Cortes & Brown, 2011). However, Immunochip has the following 
weaknesses: The chip depends on the power of the initial GWAS for its marker selection 
and does not cover the whole genome. Second, Immunochip is designed for use in white 
European populations. Third, many rare variants are not represented on the chip because 
they have yet to be identified. Another weakness is that a proportion of very rare variants 
will probably not be accurately genotyped by the chip, although based on early 
indications, the chip performs this genotyping well (Cortes & Brown, 2011). Another 
Illumina array used in the included studies was the Illumina Exome 12v1 (in which12 
denotes the number of samples that can be run on a single exome chip and v1 denotes 
version 1), hereafter referred to as an exome chip. Markers on exome chips are primarily 
exome SNPs (over 92% of the SNPs are in the exome) (Exome Chip Consortia, 2011). 
The exonic content consists of more than 240,000 markers representing diverse 
populations (European, African, Chinese, and Hispanic). The exome chip includes 
196,524 SNPs and is designed to concentrate on rare variants rather than on common 
ones. The Affymetrix and Illumina arrays increase the genomic cover for genome-wide 
analysis and for the detection of copy number variations (CNVs) compared with other 
methods (Illumina, 2015; Thermo Fisher Scientific Inc., 2017). In addition, both platforms 
have genotype calling algorithms. 
The selection of one or another tool is determined by the number of SNPs and samples 
that they can analyse, and by their yield. The genotyping platforms most frequently 
employed in the studies selected for this review were TaqMan, Sequenom, and Illumina. 
TaqMan was one of the most common techniques employed, although it has a moderate 
yield and is limited in terms of the number of SNPs and samples that can be analysed 
(Ranade et al., 2001). Another tool used was Sequenom, which enables a moderate 
number of SNPs and samples to be studied, with a high yield (thousands of genotypes per 
day) (Jurinke et al., 2002). Illumina SNP arrays have a high capacity for the analysis of 
markers (including rare variants) and samples, and with a high yield (one million 
genotypes per day) (Shen et al., 2005). PCR and its variants, PCR-RFLP and PCR-SSP, 
were the second-most frequently used tools, despite their great limitations (Dorak, 2006). 
These were followed by Affymetrix SNP arrays, enabled to analyse a high number of 
SNPs and samples, and with a high yield (one million genotypes per day) (Kennedy et al., 
2003). Like Illumina, Affymetrix allows creation of customized arrays incorporating desire 
markers, including rare variants. Another tool used was the nano-Invader, a miniaturised 
genotyping technique that, despite achieving good precision, sensitivity, speed, and yield 
in genotyping without PCR amplification, presents pipetting and evaporation issues due to 
the small sample volume used (Nomura, Kondo, Nagano, Matsui, & Egashira, 2007). Only 
two reports included in this review describe the use of this tool; both studies were written 
by the same group (Kobayashi et al., 2009a, 2009b). Later studies have used other 
genotyping tools, suggesting that because of the rapid advances in genotyping 
techniques, the nano-Invader method is less effective than its successors. Last in the list 
was SNPlex, with a high yield (thousands of genotypes per day) that allows the analysis of 
a moderate number of markers and samples (Tobler et al., 2005). 
As described above, genotyping rare variants is a difficult process but an interesting 
approach to study risk of developing a disease such as PD. Today, the best approach to 
screen for novel variations and evaluate the contribution of rare variants to complex 
diseases is sequencing by NGS and custom arrays. However, conducting whole-genome 
sequencing in large cohorts using this sequencing technology remains economically 
prohibitive. Given that 98% of the human genome is noncoding, and therefore more 
difficult to interpret, whole-exome sequencing methods were developed to sequence only 
the coding regions of the genome (exome). The Affymetrix and Illumina platforms 
introduced the Affymetrix Axiom exome array and the exome chip, respectively, as an 
affordable alternative to exome sequencing. The Axiom exome array and the exome chip 
only enable researchers to test a predetermined set of variants. In the study performed by 
Schaefer et al. in 2014 (Schaefer et al., 2014), included in the present review, a significant 
association was found between the rare variant rs62481981 at the IRF5 gene after 
covariate adjustment (p=.0012; 801 AgP, 1476 controls). However, the association lost 
significance after correction for multiple testing in the replication. Schaefer et al. 
genotyped all candidate genes with the Illumina Immunochip. The authors noted that the 
lack of statistical power was not sufficient to provide evidence of the association of less 
frequent variants. 
Therefore, due to inappropriate sample recruitment (lack of a universally accepted 
diagnostic criterion for periodontitis, the small sample size studied, and not taking into 
account ethnicity differences and environmental effects) and the poor study designs used 
to investigate genetic susceptibility (CGAS approach with low sample size, not adjusting 
for covariates, no study of rare variants, and no replication of the results in an 
independent sample), few true genetic associations for PD have been identified. 
 
Conclusions 
There are a wide variety of definitions and variables analysed to establish a diagnosis of 
PD. In addition, studies on the genetic susceptibility of PD use different criteria for 
selecting participants. All these factors make the selection of a single methodological 
strategy for the analysis of genetic susceptibility to PD a challenging task. 
Despite their inability to identify new or unexpected loci associated with PD in the genome 
and their other limitations, candidate gene studies continue to be the most widely 
employed to analyse genetic susceptibility to PD. However, with advances in scientific 
knowledge and genotyping technologies, CGSs are gradually being replaced by GWASs. 
No optimal genotyping tool yet exists for the genetic study of PD. The genotyping 
technology to be used must be considered; but also, depending on the specific human 
population that will be studied, the SNPs selected by each platform must also be taken 
into consideration. Therefore, despite the intrinsic limitations of SNP arrays, those that 
enable evaluation of specific rare population variants could be the most suitable. 
However, no studies on PD with a GWAS design that take into account rare variants have 
been published to date. 
Future studies should therefore apply strict, validated diagnostic criteria for PD, using 
large study cohorts, adjusting the results according to the relevant risk factors, and 
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Cases Controls Ethnic Group  
(Country) 
Smoking Diabetes 






(Suzuki et al., 2004) AgP 134 U and Col 40 ± 11 125 U and Col 40 ± 15 Asian 
(Japan) 
NS NS 
 CP 117 U and Col 54 ± 9       
           
(Brett et al., 2005) AgP* 51 H NS 100 Pop NS Caucasian 
(United Kingdom) 
NS NS 
 CP* 57 H NS      
           
           
(Fiebig et al., 2008) AgP 415 U 30 ± 2 874 Pop 48 ± 4 Caucasian 
(Germany and The 
Netherlands) 
S S* 
           
(Gunji et al., 2007) AgP* 25 U 33 ± 6 349 U NS Asian 
(Japan) 
NS NS 
           
(Kobayashi et al., 
2009a) 
PD* 117 DC, H and 
U 
52 ± 1 108 NS 51 ± 1 Asian 
(Japan) 
S NS 
           
           
(Kobayashiet al., 
2009b) 
AgP* 172 H 32 ± 6 303 H 38 ± 13 Asian 
(Japan) 
S S* 
 CP* 147 H 53 ± 7       
           
(Schaefer et al., 
2010a) 
AgP 283 Pop 30 ± 5 972 H 51 ± NS Caucasian 
(Germany) 
S S 
           
(Schaefer et al., 
2010b) 
AgP* 532 Pop 33 ± NS 1472 Pop 42 ± NS Caucasian 




 CP* 805 Pop 54 ± NS 319 Pop 43 ± NS    
           
(Scapoli et al., 2010) AgP
† 95 U and RC 43 ± 8 121 Col 30 ± 5 Caucasian 
(Italy) 
NS NS 
           
(Chai et al., 2010a) PD* 229 DC, H and 
U 
44 ± 7 207 DC, H and 
U 
42 ± 8 Asian 
(China) 
S S* 
           
(Chai et al., 2010b) CP
‡ 190 DC, H and 
U 
46 ± 5 169 DC, H and 
U 
45 ± 6 Asian 
(China) 
S S* 
           
(Scapoli et al., 2011) AgP
† 122 U and RC 43 ± 7 246 U 30 ± 8 Caucasian 
(Italy) 
NS NS 
           
           
(Schaefer et al., 
2011) 
AgP* 159 Pop 34 ± 5 421 Pop 32 ± 9 Caucasian 
(The Netherlands) 
S S 
 CP* 154 Pop 45 ± 10  Pop     
           
           
(Letra et al., 2012) CP 169 U and Col 50 ± NS 506 U and Col 46 ± NS Caucasian 
(Brazil and USA) 
NS NS 
           
           
(Atanasovska-
Stojanovska et al., 
2013) 
CP* 114 U 39 ± 10 301 U 35 ± 10 NS (Macedonia) NS NS 
           
           
(Schaefer et al., 
2013) 
AgP 600 Pop NS 1448 Pop NS Caucasian 
(Germany) 
S NS 




Abbreviations: PD, periodontal disease; AgP, aggressive periodontitis; CP, chronic periodontitis; S, specified; NS, not 
specified. S*, specified as exclusion criterion; U, university; H, hospital; DC, dental clinic; RC, research centre; Col, 
College of Dentists; Pop, general population. 
*Armitage, 1999 (Armitage, 1999). 
†
Lang et al., 1999 (Lang et al., 1999). 
‡ 
Fleming, 1999 (Flemmig, 1999). 














(de Jong et al., 
2014) 
AgP 283 Pop 30 ± 5  979 Pop 51 ± 13 Caucasian 
(Germany) 
S S 
            
            
(Feng et al., 2014) CP 712 U 57 ± NS  1973 U 55 ± NS Caucasian, African 
and other (Brazil 
and USA) 
S S 
            
            
(Schaefer et al., 
2014) 
AgP 828 Pop NS  2119 Pop and U NS Caucasian 
(Germany and The 
Netherlands) 
S NS 
            
            
(Zhang et al., 2014) CP* 400 Pop 50 ± 9  750 Pop 50 ± 8 Asian (China) S* S 
 
            
            
            
(Schaefer et al., 
2015) 
AgP 1042 U NS  3094 Pop NS Caucasian 
(Germany and The 
Netherlands) 
S S* 
            
(Shang et al., 2016) CP 471 H NS  1312 Pop NS Asian (China) S S* 
            
            
(Offenbacher et al., 
2016) 
AgP 717 U NS  4210 Pop NS Caucasian 
(Germany) 
S S 
            
(Zupin et al., 2017) CP* 399 Pop NS  148 Pop NS Caucasian (Italy) S NS 
            
            





Table 2. Clinical parameters recorded in publications included in the review. 




PPD CAL BOP Alveolar bone loss Others 
      
(Suzuki et al., 2004) R NR R R: On x-rays Degree of tooth mobility 
(Brett et al., 2005) NR NR NR NR X-rays and 6-point periodontal probing 
(Fiebig et al., 2008) NR NR NR R:  On x-rays Number of teeth present 
(Gunji et al., 2007) R NR NR NR Number of natural teeth present 
(Kobayashi et al., 2009a) R R R NR Number of missing teeth, accumulation of supragingival plaque, mean distance from the free 
gingival margin to bottom of pocket and mean distance from the cement-enamel junction to bottom 
of pocket 
(Kobayashiet al., 2009b) R R R R: On x-rays (2 sites per tooth) Number of natural teeth, presence/absence of supragingival plaque (4 sites per tooth) 
(Schaefer et al., 2010a) NR NR NR R: On x-rays  NR 
      
(Schaefer et al., 2010b) R R R R: On x-rays and orthopantomography Number of natural teeth and of exposed furcations 
(Scapoli et al., 2010) NR NR NR NR Loss of interproximal insertion > 2 mm on probing of any tooth 
(Chai et al., 2010a) R R R R: On orthopantomography NR 
(Chai et al., 2010b) R R R NR Number of natural teeth 
(Scapoli et al., 2011) NR NR NR NR Interproximal insertion loss > 2 mm on probing of any tooth 
(Schaefer et al., 2011) R R R R: On x-rays and orthopantomography Number of natural teeth and of exposed furcations 
(Letra et al., 2012) R R NR NR NR 
(Atanasovska-Stojanovska et al., 
2013) 
R R R NR Löe and Silness gingival index 
(Schaefer et al., 2013) NR NR NR R: On x-rays NR 
(de Jong et al., 2014) NR NR NR R NR 
(Feng et al., 2014) NR R NR NR NR 
(Schaefer et al., 2014) NR NR NR R: On x-rays Number of natural teeth and of exposed furcations 
(Zhang et al., 2014) R R R R: Vertical or horizontal loss of alveolar bone Degree of gingival recession, tooth mobility and chronic gingival bleeding 
(Schaefer et al., 2015) NR NR NR R: On x-rays and orthopantomography NR 
(Shang et al., 2016) R R NR NR NR 
(Offenbacher et al., 2016) R R R NR Number of missing teeth, gingival index and plaque index 
(Zupin et al., 2017) R R R NR X-rays, number of teeth present, O´Leary plaque index and gingival recession 
(Munz et al., 2017) NR NR NR NR NR 
























Reference Reasons for Exclusion 
  
(Divaris et al., 2012) Investigation of the susceptibility loci for colonisation with periodontal microbiota. 
  
(Divaris et al., 2013) The control group was formed of individuals with mild periodontitis. 
  
(Teumer et al., 2013) The control group was formed of individuals with mild periodontitis. 
  
(Rhodin et al., 2014) The control group was formed of individuals with mild periodontitis. 
  
(Shaffer et al., 2014) Not a case-control study. Analysis of two distinct phenotypes related to CP. 
  
(Freitag-Wolf et al., 
2014) 
Selected only sex-specific SNPs. 
  
(Hong et al., 2015) The control group was formed of individuals with a healthy periodontium or mild periodontitis. 
  
(Shimizu et al., 2015) The control group was formed of individuals with systemic diseases (cerebral aneurysm, oesophageal 
cancer, endometrial cancer, chronic obstructive pulmonary disease or glaucoma). 
  
(Sanders et al., 2017) Not a case-control study. 
  









OR 95%CI Association 
       
       
(Suzuki et al., 2004) 310 TaqMan COL1A1 (NA) 2.5 1.4-4.6 AgP 
   COL4A1 (NA) 2.1 1.3-3.5 AgP 
   PTGDS (NA) 5.1 1.5-18.2 AgP 
   KRT23 (NA) 6.3 1.4-29.2 AgP 
   IL6ST (NA) NA NA AgP 
   CTSD (NA) 3.2 1.6-6.5 CP 
   EGF (NA) 4.8 1.5-14.7 CP 
   CTSD (NA) NA NA CP 
   HSPG2(NA) NA NA CP 
   COL17A1(NA) NA NA CP 
       
(Brett et al., 2005) 10 PCR IL1B(NA) 3.6 1.4-9.7 AgP 
 
  
IL6(NA) 3.1 1.5-6.3 AgP and CP 
 
  
VDR (NA) 2.7 1.4-5.4 CP 
 
  
TLR4(NA) 3.0 1.2-7.6 PD 
       
(Fiebig et al., 2008) 10 TaqMan ND ND ND ND 
       
(Gunji et al., 2007) 30 PCR-RFLP FPR1 (rs11666254) 2.0 NA AgP 
       
 
  
FPR1 (rs12460836) 2.0 NA AgP 
      
(Kobayashi et al., 
2009a) 
16 Novel nano-Invader DNA chip 
system 
ND ND ND ND 
       
(Kobayashi et al., 
2009b) 
35 Novel nano-Invader DNA chip 
system, (PCR)-Invader and 
TaqMan 
VDR (NA) 2.5 1.4-4.3 CP 
       
(Schaeferet al., 
2010a) 
500.568 Affymetrix Human Mapping 
500k Array set and Affymetrix 
Genome-Wide Human SNP 











       
(Schaefer et al., 
2010b) 
12 SNPlex and TaqMan DEFB1 (rs1047031) 1.3 1.1-1.6 AgP and CP 
       
(Scapoli et al., 
2010) 
70 Sequenom MassARRAY 
ND ND ND ND 
       
(Chai et al., 2010a) 11 iPLEX Sequenom MassARRAY C5 (rs17611) 6.1 1.3-28.2 PD 
       
(Chai et al., 2010b) 102 iPLEX Sequenom MassARRAY FCGR3A (rs445509) 1.0 0.5-0.8 CP 
       
(Scapoli et al., 
2011) 
28 Sequenom MassARRAY and 
PCR 
IL6(NA) 2.5 1.5-4.4 AgP  
       
(Schaefer et al., 
2011) 
51/37* SNPlex and TaqMan CDKN2B 
(rs3217992) 
2.5 1.3-5.1 AgP 
       
   CDKN2B-AS1 
(rs518394) 
2.3 1.1-4.9 AgP 
 
   CDKN2B-AS1 
(rs1360590) 
2.6 1.3-5.2 AgP 
       
   CDKN2B-AS1 
(rs11790231) 
NA NA AgP 
 
 
   CDKN2B-AS1 
(rs1360590) 
 





NA NA CP 
       
(Letra et al., 2012) 34 TaqMan TIMP1 (rs5906435) NA NA CP 
  
 
MMP3 (rs679620) NA NA CP 
  
 
MMP3 (rs650108) NA NA CP 
       
(Atanasovska-
Stojanovska et al., 
2013) 
22 PCR-SSP IL1B (NA) 2.1 1.4-3.3 CP 
       (Schaefer et al., 2013) 268 Illumina Inmunochip Upstream of IL10 
(rs61815643) 
0.8 0.7-0.9 AgP 
       
   Upstream of IL10 
(rs6667202) 
0.8 0.7-0.9 AgP 
       
   Upstream of IL10 
(rs4072226) 
0.8 0.7-1.0 AgP 
       
(de Jong et al., 2014) 27 Affymetrix Human Mapping 



























1.4 1.0-2.1 AgP 
       




NA NA CP 

















NA NA CP 
       
(Schaefer et al., 2014) ~3.000 Illumina Inmunochip IRF5 (rs62481981) 3.1 1.6-6.1 AgP 
       
   PRDM1 
(rs6923419) 
0.7 0.6-0.9 AgP 
       
(Zhang et al., 2014) 23 iPLEX Sequenom 
MassARRAY 
IL8 (rs4073) 1.2 1.0-1.4 CP 
 
 
(Schaefer et al., 2015) 46 Illumina Inmunochip and 
Affymetrix Human Mapping 
500K Array set 
PLG (rs4252120) 1.3 1.3-1.4 AgP 
       
(Shang et al., 2016) 65 Sequenom MassARRAY FBXO38 
(rs10043775) 
1.2 NA CP 
       




Illumina Human BeadChips ND ND ND ND 
       
(Zupin et al., 2017) 203 Illumina Exome 12v1 NLRC5 (rs289723) 2.0 1.3-3.1 CP 
(Munz et al., 2017) 502.332/15˄ iPLEX Sequenom 
MassARRAY, Illumina Human 
EFA1A3 
(rs297851) 
1 3 2 1 4
 
Abbreviations: PD, periodontal disease; AgP, aggressive periodontitis; CP, chronic periodontitis; OR, odds ratio; CI, 
confidence interval; ND, no data; NA, data not available. 
* In the association study for AgP, 51 SNPs were analysed. In the association study for CP, 37 SNPs were analysed. 
† 
In the association study for CP, 620 901 SNPs were analysed. An independent test for CP was performed in two 
Caucasians populations (Porto Alegro and Río de Janeiro), analysing 20 SNPs. 
ʹ In the association study for CP, 2.135.235SNPs were analysed. An independent test for CP was performed in German 
sample, analysing 47 SNPs. 
˄ 
In the discovery stage 502.332 SNPs were analysed. A replication was performed in a sample of Turkish descent, 
analysing 15 SNPs. 
 
OmniBeadChip and TaqMan 
   DEFA1A3 
(rs2738058) 
1.3 1.1-1.4 AgP 
       
   SIGLEC5 
(rs4284742) 
1.3 1.2-1.5 AgP 
       
   SLC1A3 
(rs1122900) 

































Articles valid for full-text reading (n = 87) 









Articles identified in the 
PubMed search (n = 2392) 
Articles identified in the 
Cochrane search (n = 47) 




























Duplicate articles (n = 27) 
Articles excluded during evaluation of the title/abstract, with 
reasons (n = 2325) 
Articles suitable for data extraction and inclusion in the review  
(n = 25) 
 
- Only abstract in English (n=126) 
- Reviews and/or meta-analysis (n=148) 
- Focusing on treatment (n=72) 
- Focusing on microbial data (n=680) 
- Expression studies (n=163) 
- Focusing in other pathologies (n=489) 
- Focusing on pregnancy or preterm birth (n=9) 
- Focusing on epigenetics (n=8) 
- Focusing on tools, functional studies, studies at 
cellular level, microsatellites and others (n=205) 
- Not case-control study (n=82)       
- <10 SNPs studied (n=159) 
- Group of cases and controls composed for < 100 
individuals (n=168) 
- Groups studied with potential biases (n=16) 
- Reviews and/or meta-analysis (n=7) 
- Not case-control study (n=3)       
- Group of cases and controls composed for < 100 
individuals (n=13) 
- <10 SNPs studied (n=33) 
- Groups studied with potential biases (n=6) 
 
Additional records identified 
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